PERINATOLOGY • Vol 24 • No. 1 • May–Aug 2023 • 33 Original Article Sampagar A, et al. Feasibility and Cost Analysis of Antenatal Screening and Diagnosis of Hemoglobinopathies Authors’ Affiliations Dr Abhilasha Sampagar, Professor, Department of Medical Oncology; Dr Niranjana Shambhulingappa Mahantashetti, Professor, Department of Pediatrics and Principal; Dr Hema Patil, Associate Professor, Department of Obstetrics and Gynecology; Dr Manjunath Hukkeri, Assistant Professor, Department of Obstetrics and Gynecology; Dr Ranjit Kangle, Professor and Head, Department of Pathology; Dr Manjunath Somappa Somannavar, Professor, Department of Biochemistry; Dr Shivprasad Goudar, Professor, Department of Physiology, KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Nehru Nagar, Belagavi 590019, Karnataka, India; Dr Neha Giridhar Patil, Junior Resident, Father Muller Medical College, Kankanady, Mangaluru 575002, Karnataka, India 19. Hossain MS, et al. Thalassemias in South Asia: clinical lessons learnt from Bangladesh. Orphanet J Rare Dis. 2017;12(1):1–9. 20. KorenA, et al. Prevention of β thalassemia in Northern Israel - a cost-benefit analysis. Mediterranean J Hematol Infect Dis. 2014;6(1):e2014012. 21. Esmaeilzadeh F, et al. Economic burden of thalassemia major in Iran, 2015. J Res Health Sci. 2016;16(3):111–115. 22. Emamgholipour S, et al. Cost-utility of treatment of the patients with thalassemia major in Iran. Sci J Iran Blood Transfus Org. 2018;15(4):257–264. 23. Cousens NE, et al. Carrier screening for beta-thalassaemia: a review of international practice. European J Human Genetics. 2010;18(10):1077–1083. 24. CaoA, KanYW. The prevention of thalassemia. Cold Spring Harbor Perspect Med. 2013;3(2):a011775. 25. Tuli A, Yenilmez ED. Invasive and noninvasive approaches in prenatal diagnosis of thalassemias. In: Al-Zwaini I, ed. Thalassemia and Other Hemolytic Anemias. InTech. 2018. http://dx.doi.org/10.5772/intechopen.75570. Accessed May 8, 2023. 26. Gupta V, et al. Screening for thalassemia carrier status in pregnancy and pre-natal diagnosis. Indian Pediatr. 2015;52(9):808–809. 27. Shukla S, et al. Antenatal carrier screening for thalassemia and related hemoglobinopathies: a hospital-based study. J Med Soc. 2018;32(2):118–112. 28. Satpute SB, Bankar MP, Momin AA. The prevalence of β-thalassemia mutations in south westernMaharashtra. Indian J Clin Biochem. 2012;27(4):389–393. 29. Vehapoglu A, et al. Hematological indices for differential diagnosis of beta thalassemia trait and iron deficiency anemia. Anemia. 2014;2014:576738. 30. Kar YD, et al. Erythrocyte indices as differential diagnostic biomarkers of iron deficiency anemia and thalassemia. J Pediatr Hematol Oncol. 2020;42(3):208–213. 31. Edison ES, et al. Analysis of beta globin mutations in the Indian population: presence of rare and novel mutations and region-wise heterogeneity. Clin Genet. 2008;73(4):331–337. 32. Panigrahi I, Marwaha RK. Mutational spectrum of thalassemias in India. Indian J Hum Genet. 2007;13(1):36–37. 33. Moirangthem A, Phadke SR. Socio-demographic profile and economic burden of treatment of transfusion dependent thalassemia. Indian J Pediatr. 2018;85(2):102107.
RkJQdWJsaXNoZXIy MjAwNDg=